Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (211-220 of 1,622) with videos related to

Pageof 163
Sort By:
Gynecologic Oncology|June 2, 2009
The impact of PET-CT in suspected recurrent ovarian cancer: a prospective multi-centre study as part of the Australian PET Data Collection ProjectMaurie Markman
Oncology|January 27, 2009
Therapeutic intent in the conduct of phase I antineoplastic drug trialsMaurie Markman
F1000 Medicine Reports|October 16, 2010
Recent studies that influence the chemotherapeutic paradigm in the management of advanced ovarian cancerMaurie Markman
Gynecologic Oncology|June 4, 2013
Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancerMaurie Markman
Current Oncology Reports|February 23, 2013
Provider impact on survival outcomes in the management of malignant diseaseMaurie Markman
Expert Review of Clinical Pharmacology|February 5, 2014
Advances in cervical cancer pharmacotherapiesMaurie Markman
Seminars in Oncology|September 1, 1985
Melphalan and cytarabine administered intraperitoneally as single agents and combination intraperitoneal chemotherapy with cisplatin and cytarabineM Markman
The American Journal of Bioethics : AJOB|April 16, 2014
Challenging the requirements for disclosing risk to clinical research participantsMaurie Markman
Oncology|April 15, 2008
Development of an effective breast and cervix cancer screening strategy in Mumbai: an impressive effortMaurie Markman
Expert Review of Anticancer Therapy|February 19, 2008
Taxanes in the management of gynecologic malignanciesMaurie Markman
Pageof 163

Showing results (211-220 of 1,622) with videos related to

Sort By:
Pageof 163
Gynecologic Oncology|June 2, 2009
The impact of PET-CT in suspected recurrent ovarian cancer: a prospective multi-centre study as part of the Australian PET Data Collection ProjectMaurie Markman
Oncology|January 27, 2009
Therapeutic intent in the conduct of phase I antineoplastic drug trialsMaurie Markman
F1000 Medicine Reports|October 16, 2010
Recent studies that influence the chemotherapeutic paradigm in the management of advanced ovarian cancerMaurie Markman
Gynecologic Oncology|June 4, 2013
Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancerMaurie Markman
Current Oncology Reports|February 23, 2013
Provider impact on survival outcomes in the management of malignant diseaseMaurie Markman
Expert Review of Clinical Pharmacology|February 5, 2014
Advances in cervical cancer pharmacotherapiesMaurie Markman
Seminars in Oncology|September 1, 1985
Melphalan and cytarabine administered intraperitoneally as single agents and combination intraperitoneal chemotherapy with cisplatin and cytarabineM Markman
The American Journal of Bioethics : AJOB|April 16, 2014
Challenging the requirements for disclosing risk to clinical research participantsMaurie Markman
Oncology|April 15, 2008
Development of an effective breast and cervix cancer screening strategy in Mumbai: an impressive effortMaurie Markman
Expert Review of Anticancer Therapy|February 19, 2008
Taxanes in the management of gynecologic malignanciesMaurie Markman
Pageof 163